You are here: Home » Companies » Industry

Medical devices regulation 2.0 draws industry's ire

The new draft wants companies to specify manufacturing date along with expiry date on packaging

The second draft of the regulations, which were notified by the Union health ministry on Wednesday, four months after the first draft was issued, have once again drawn industry flak. The fresh rules, while dividing the into four groups on the basis of risk, have capped their shelf life at five years. Companies, mostly multinationals (MNCs), protested saying the rules were too stringent, citing global norm of 10-year validity for medical devices.         

Among other guidelines, the new draft wants companies to specify manufacturing date along with expiry date on packaging. This move, according to MNCs, will restrict import of devices into India.

Overall, the import laws for have been made tougher. For instance, the licensing authority will not allow import of any medical device, whose total shelf-life claim is less than three months and if it has less than 40 per cent residual shelf-life as on date of import.

The draft rules also highlight the need for the government regulating the sector due to the inherent risk. But, industry has opposed that too, saying companies should be able to self-regulate.

According to Pavan Choudary, director-general of the newly formed Medical Technology Association of India, the draft does not reflect the various discussions that took place between industry and the government. He told Business Standard: “Draft rules are giving a conflicting signal and do not convey the spirit of discussions held with the health ministry.”

Speaking on the issue of shelf-life, an executive at a foreign manufacturing company asked, “While global norms allow shelf life up to 10 years, why should India have a shelf life that is half of that?” Some domestic manufacturers joined in, saying should have a much higher shelf life than five years, as the draft states.

The tightening of the import laws for may help domestic players though. Rajiv Nath of Association of Industry in India said the draft was “against the whole concept of Make in India”. He said, “Why should companies that are already approved by the quality standards check have to go through further scrutiny? Why should the CDSCO (Central Drugs Standard Control Organization) keep monitoring us? CDSCO does not have the capability to keep a check on quality. They should allow self-regulation.”

Nath also argues that manufacturers should get two to three years’ transition period for capacity building for implementing these rules.

image
Business Standard
177 22
Business Standard

Medical devices regulation 2.0 draws industry's ire

The new draft wants companies to specify manufacturing date along with expiry date on packaging

Veena Mani  |  New Delhi 

Medical devices regulation 2.0 draws industry's ire

The second draft of the regulations, which were notified by the Union health ministry on Wednesday, four months after the first draft was issued, have once again drawn industry flak. The fresh rules, while dividing the into four groups on the basis of risk, have capped their shelf life at five years. Companies, mostly multinationals (MNCs), protested saying the rules were too stringent, citing global norm of 10-year validity for medical devices.         

Among other guidelines, the new draft wants companies to specify manufacturing date along with expiry date on packaging. This move, according to MNCs, will restrict import of devices into India.


Overall, the import laws for have been made tougher. For instance, the licensing authority will not allow import of any medical device, whose total shelf-life claim is less than three months and if it has less than 40 per cent residual shelf-life as on date of import.

The draft rules also highlight the need for the government regulating the sector due to the inherent risk. But, industry has opposed that too, saying companies should be able to self-regulate.

According to Pavan Choudary, director-general of the newly formed Medical Technology Association of India, the draft does not reflect the various discussions that took place between industry and the government. He told Business Standard: “Draft rules are giving a conflicting signal and do not convey the spirit of discussions held with the health ministry.”

Speaking on the issue of shelf-life, an executive at a foreign manufacturing company asked, “While global norms allow shelf life up to 10 years, why should India have a shelf life that is half of that?” Some domestic manufacturers joined in, saying should have a much higher shelf life than five years, as the draft states.

The tightening of the import laws for may help domestic players though. Rajiv Nath of Association of Industry in India said the draft was “against the whole concept of Make in India”. He said, “Why should companies that are already approved by the quality standards check have to go through further scrutiny? Why should the CDSCO (Central Drugs Standard Control Organization) keep monitoring us? CDSCO does not have the capability to keep a check on quality. They should allow self-regulation.”

Nath also argues that manufacturers should get two to three years’ transition period for capacity building for implementing these rules.

RECOMMENDED FOR YOU

Medical devices regulation 2.0 draws industry's ire

The new draft wants companies to specify manufacturing date along with expiry date on packaging

The new draft wants companies to specify manufacturing date along with expiry date on packaging
The second draft of the regulations, which were notified by the Union health ministry on Wednesday, four months after the first draft was issued, have once again drawn industry flak. The fresh rules, while dividing the into four groups on the basis of risk, have capped their shelf life at five years. Companies, mostly multinationals (MNCs), protested saying the rules were too stringent, citing global norm of 10-year validity for medical devices.         

Among other guidelines, the new draft wants companies to specify manufacturing date along with expiry date on packaging. This move, according to MNCs, will restrict import of devices into India.

Overall, the import laws for have been made tougher. For instance, the licensing authority will not allow import of any medical device, whose total shelf-life claim is less than three months and if it has less than 40 per cent residual shelf-life as on date of import.

The draft rules also highlight the need for the government regulating the sector due to the inherent risk. But, industry has opposed that too, saying companies should be able to self-regulate.

According to Pavan Choudary, director-general of the newly formed Medical Technology Association of India, the draft does not reflect the various discussions that took place between industry and the government. He told Business Standard: “Draft rules are giving a conflicting signal and do not convey the spirit of discussions held with the health ministry.”

Speaking on the issue of shelf-life, an executive at a foreign manufacturing company asked, “While global norms allow shelf life up to 10 years, why should India have a shelf life that is half of that?” Some domestic manufacturers joined in, saying should have a much higher shelf life than five years, as the draft states.

The tightening of the import laws for may help domestic players though. Rajiv Nath of Association of Industry in India said the draft was “against the whole concept of Make in India”. He said, “Why should companies that are already approved by the quality standards check have to go through further scrutiny? Why should the CDSCO (Central Drugs Standard Control Organization) keep monitoring us? CDSCO does not have the capability to keep a check on quality. They should allow self-regulation.”

Nath also argues that manufacturers should get two to three years’ transition period for capacity building for implementing these rules.
image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard